JP2022516631A5 - - Google Patents
Info
- Publication number
- JP2022516631A5 JP2022516631A5 JP2021538743A JP2021538743A JP2022516631A5 JP 2022516631 A5 JP2022516631 A5 JP 2022516631A5 JP 2021538743 A JP2021538743 A JP 2021538743A JP 2021538743 A JP2021538743 A JP 2021538743A JP 2022516631 A5 JP2022516631 A5 JP 2022516631A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- independently
- disease
- substituted
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962788049P | 2019-01-03 | 2019-01-03 | |
| US62/788,049 | 2019-01-03 | ||
| US201962879374P | 2019-07-26 | 2019-07-26 | |
| US62/879,374 | 2019-07-26 | ||
| PCT/US2020/012268 WO2020142748A1 (en) | 2019-01-03 | 2020-01-03 | Methods and materials for increasing transcription factor eb polypeptide levels |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022516631A JP2022516631A (ja) | 2022-03-01 |
| JP2022516631A5 true JP2022516631A5 (cg-RX-API-DMAC10.html) | 2023-01-06 |
| JP7566753B2 JP7566753B2 (ja) | 2024-10-15 |
Family
ID=71406977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021538743A Active JP7566753B2 (ja) | 2019-01-03 | 2020-01-03 | 転写因子ｅｂポリペプチドレベルを増加させるための方法および材料 |
Country Status (12)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4178955A1 (en) | 2020-07-11 | 2023-05-17 | Pfizer Inc. | Antiviral heteroaryl ketone derivatives |
| US11351149B2 (en) | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
| CZ309449B6 (cs) * | 2020-12-24 | 2023-01-25 | Ústav experimentální botaniky AV ČR, v. v. i. | Chinazolinové deriváty jako selektivní inhibitory cyklooxygenázy-1 |
| CN113248518B (zh) * | 2021-06-21 | 2022-03-25 | 山东大学 | 嘧啶哌嗪类衍生物及其制备方法与应用 |
| CN121941701A (zh) * | 2023-07-28 | 2026-04-28 | 特兰埃克斯公司 | 用于治疗溶酶体病症的突变tfeb |
| CN119818678A (zh) * | 2024-12-24 | 2025-04-15 | 广州医科大学附属妇女儿童医疗中心 | Tfeb在制备变应性鼻炎的药物中的应用 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5304121A (en) | 1990-12-28 | 1994-04-19 | Boston Scientific Corporation | Drug delivery system making use of a hydrogel polymer coating |
| US5994341A (en) | 1993-07-19 | 1999-11-30 | Angiogenesis Technologies, Inc. | Anti-angiogenic Compositions and methods for the treatment of arthritis |
| US6099562A (en) | 1996-06-13 | 2000-08-08 | Schneider (Usa) Inc. | Drug coating with topcoat |
| AU2001290912A1 (en) * | 2000-09-15 | 2002-03-26 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| CA2446904A1 (en) | 2001-05-24 | 2003-04-03 | Alexza Pharmaceuticals, Inc. | Delivery of drug esters through an inhalation route |
| US20030158195A1 (en) * | 2001-12-21 | 2003-08-21 | Cywin Charles L. | 1,6 naphthyridines useful as inhibitors of SYK kinase |
| US7262200B2 (en) | 2002-10-25 | 2007-08-28 | Vertex Pharmaceuticals Incorporated | Indazolinone compositions useful as kinase inhibitors |
| CL2004000409A1 (es) * | 2003-03-03 | 2005-01-07 | Vertex Pharma | Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu |
| US7198926B2 (en) | 2003-05-08 | 2007-04-03 | E. I. Du Pont De Nemours And Company | Preparation of (E)- and (Z)-2-methyl-2-butenoic acids |
| JP2006528694A (ja) | 2003-05-13 | 2006-12-21 | スミスクライン ビーチャム コーポレーション | ナフチリジンインテグラーゼインヒビター |
| WO2008157500A1 (en) | 2007-06-17 | 2008-12-24 | Kalypsys, Inc. | Aminoquinazoline cannabinoid receptor modulators for treatment of disease |
| WO2009062118A2 (en) * | 2007-11-07 | 2009-05-14 | Foldrx Pharmaceuticals, Inc. | Modulation of protein trafficking |
| US8604049B2 (en) * | 2008-08-05 | 2013-12-10 | Boehringer Ingelheim International Gmbh | 4-dimethylamino-phenyl-substituted naphthyridines, and use thereof as medicaments |
| JP2011529932A (ja) * | 2008-08-05 | 2011-12-15 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 置換ナフチリジン及び医薬としてのその使用 |
| GB201007203D0 (en) * | 2010-04-29 | 2010-06-16 | Glaxo Group Ltd | Novel compounds |
| GB201007347D0 (en) | 2010-04-30 | 2010-06-16 | Karus Therapeutics Ltd | Compounds |
| RU2015120217A (ru) | 2012-11-20 | 2017-01-10 | Ф. Хоффманн-Ля Рош Аг | Замещенные 1,6-нафтиридины |
| EP4026545A1 (en) | 2014-11-19 | 2022-07-13 | Rush University Medical Center | Compositions and methods for treating lysosomal disorders |
| EP3538091A4 (en) * | 2016-11-08 | 2020-06-10 | Navitor Pharmaceuticals, Inc. | PHENYL AMINO PIPERIDINE MTORC INHIBITORS AND USES THEREOF |
| WO2018089433A1 (en) | 2016-11-08 | 2018-05-17 | Navitor Pharmaceuticals, Inc. | PHENYL mTORC INHIBITORS AND USES THEREOF |
| WO2018089493A1 (en) * | 2016-11-08 | 2018-05-17 | Navitor Pharmaceuticals, Inc. | PYRROLE mTORC INHIBITORS AND USES THEREOF |
| WO2018191146A1 (en) * | 2017-04-10 | 2018-10-18 | Navitor Pharmaceuticals, Inc. | Heteroaryl rheb inhibitors and uses thereof |
-
2020
- 2020-01-03 SG SG11202105685TA patent/SG11202105685TA/en unknown
- 2020-01-03 EP EP20736104.9A patent/EP3906033A4/en active Pending
- 2020-01-03 JP JP2021538743A patent/JP7566753B2/ja active Active
- 2020-01-03 AU AU2020204717A patent/AU2020204717B2/en active Active
- 2020-01-03 CA CA3123902A patent/CA3123902A1/en active Pending
- 2020-01-03 CN CN202080007921.4A patent/CN113316453B/zh active Active
- 2020-01-03 MX MX2021008152A patent/MX2021008152A/es unknown
- 2020-01-03 WO PCT/US2020/012268 patent/WO2020142748A1/en not_active Ceased
- 2020-01-03 US US17/420,597 patent/US12286442B2/en active Active
- 2020-01-03 KR KR1020217022772A patent/KR102904932B1/ko active Active
- 2020-01-03 BR BR112021012950-2A patent/BR112021012950A2/pt unknown
-
2021
- 2021-06-27 IL IL284403A patent/IL284403A/en unknown
-
2025
- 2025-01-23 US US19/035,805 patent/US20250382309A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7652865B2 (ja) | Ｒｏｃｋ阻害剤としての重水素化合物 | |
| US20240352031A1 (en) | Thieno[2,3-D]pyrimidin-4-one Derivatives as NMDAR Modulators and Uses Related Thereto | |
| JP5778353B2 (ja) | アゼチジン化合物、組成物及び可溶性エポキシド加水分解酵素の阻害剤としてのそれらの使用 | |
| CN85107020A (zh) | 烷基亚磺酰胺基苯基烷基胺的制备方法 | |
| JP2013541596A5 (cg-RX-API-DMAC10.html) | ||
| US7595403B2 (en) | Benzisothiazol-3-one-carboxylic acid amides as phospholipase inhibitors | |
| CN1646538A (zh) | 托吡酯盐及其组合物、制备方法和应用 | |
| JP6363164B2 (ja) | ヒストンデアセチラーゼ阻害剤及びその組成物と使用方法 | |
| JP2018537413A (ja) | Ｃｆｔｒを調節するための化合物、組成物、および方法 | |
| PE20240655A1 (es) | Derivados de acido 4-(2-fluoro-4-metoxi-5-3-(((1-metilciclobutil)metil)carbamoil)biciclo[2.2.1]heptan-2-il)carbamoil)fenoxi)-1-metilciclohexano-1-carboxilico y compuestos similares como moduladores de rxfp1 para el tratamiento de insuficiencia cardiaca | |
| JP2010138206A (ja) | 新規な複素環式化合物 | |
| JP2005516067A5 (cg-RX-API-DMAC10.html) | ||
| CA2472149A1 (en) | New fluorenecarboxylic acid esters, process for the manufacture thereof and use thereof as medicaments | |
| US20250382309A1 (en) | Methods and materials for increasing transcription factor eb polypeptide levels | |
| CA2471578A1 (en) | Xanthene-carboxylic acid esters of tropenol and scopine as m3 antagonists, method for producing the same and use thereof as medicaments | |
| WO2010051819A1 (en) | Novel 2,3-diamino-quinazolinone derivatives and their medical use | |
| JP2014506602A5 (cg-RX-API-DMAC10.html) | ||
| US20110312962A1 (en) | Novel 2-morpholino-3-amido-pyridine derivatives and their medical use | |
| JP2023536511A5 (cg-RX-API-DMAC10.html) | ||
| JP2009532413A5 (cg-RX-API-DMAC10.html) | ||
| US9388166B2 (en) | 6-aminoindole derivatives as TRP channel antagonists | |
| MXPA06003770A (es) | Medios desechables en un panal absorbente. | |
| US20110003867A1 (en) | Novel 2-ethyl-methyl-amino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators | |
| RU2021122937A (ru) | Способы и материалы для повышения уровней полипептида фактора транскрипции eb | |
| JP7862858B2 (ja) | Ｍｐｓ１を処置するための併用療法 |